Rapport Therapeutics, Inc. Common Stock
RAPP
$30.15-1.63%
End of day · as of Oct 13, 2026, 2:30 AM ET
Mkt cap
$532.87M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
N/A
EPS (H1 2026)
$-1.61
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported RAPP revenue for 2026-06-30 was $0. Net income was -$56.6M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
Use this RAPP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RAPP income, balance, and cash tables.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company in the Healthcare sector.
Latest cached Rapport Therapeutics, Inc. Common Stock (RAPP) net income for Jun 30, 2026 was -$56.6M. Statements: https://lician.com/financials/rapp
Rapport Therapeutics, Inc. Common Stock (RAPP) market capitalization is $532.9M on the latest cached snapshot.
Rapport Therapeutics, Inc. Common Stock (RAPP) cached previous close $30.65; day range $30.15 – $30.65; volume 126,879. Session quote: https://lician.com/quote/rapp
Rapport Therapeutics, Inc. Common Stock (RAPP) latest cached earnings event is "RAPP earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RAPP filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/rapp